ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Infectious Disease

Top Infectious Disease Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHARLES LEVY MD

Infectious Disease

439

$464K

45
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 62%

$1056
Average prescription price

Avg: $471

JOSE BORDON MD

Infectious Disease

557

$477K

53
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 62%

$857
Average prescription price

Avg: $471

ANDREW CATANZARO MD

Infectious Disease

1,337

$1.12M

70
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

80%
prescriptions for brand name drugs

Avg: 62%

$838
Average prescription price

Avg: $471

PRINCY KUMAR

Infectious Disease

298

$216K

19
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 62%

$724
Average prescription price

Avg: $471

MARIA RUIZ MD

Infectious Disease

427

$282K

45
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 62%

$661
Average prescription price

Avg: $471

AFSOON ROBERTS MD

Infectious Disease

1,164

$749K

61
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 62%

$643
Average prescription price

Avg: $471

YUGENIA HONG-NGUYEN M.D.

Infectious Disease

333

$210K

26
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 62%

$632
Average prescription price

Avg: $471

GEBEYEHU TEFERI M.D.

Infectious Disease

2,089

$1.31M

97
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 62%

$627
Average prescription price

Avg: $471

JESSICA ROSEN

Infectious Disease

411

$250K

42
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 62%

$609
Average prescription price

Avg: $471

DAVID PARENTI M.D.

Infectious Disease

973

$587K

58
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 62%

$603
Average prescription price

Avg: $471

JOSEPH TIMPONE

Infectious Disease

693

$415K

32
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 62%

$598
Average prescription price

Avg: $471

MARY YOUNG

Infectious Disease

505

$302K

23
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

76%
prescriptions for brand name drugs

Avg: 62%

$597
Average prescription price

Avg: $471

LAURA COSTER MD

Infectious Disease

422

$242K

40
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 62%

$573
Average prescription price

Avg: $471

LEON LAI MD

Infectious Disease

719

$411K

72
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 62%

$572
Average prescription price

Avg: $471

ROXANNE COX IYAMU M.D.

Infectious Disease

653

$368K

28
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 62%

$563
Average prescription price

Avg: $471

JOSE CHAVEZ MD

Infectious Disease

1,358

$735K

75
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 62%

$541
Average prescription price

Avg: $471

SARAH HENN M.D.,MPH

Infectious Disease

3,682

$1.89M

135
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 62%

$512
Average prescription price

Avg: $471

LELEKA DOONQUAH MD

Infectious Disease

3,028

$1.51M

107
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 62%

$500
Average prescription price

Avg: $471

VERONICA JENKINS MD

Infectious Disease

2,858

$1.34M

113
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 62%

$468
Average prescription price

Avg: $471

JOSEPH CASAZZA MD

Infectious Disease

995

$463K

25
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 62%

$466
Average prescription price

Avg: $471

SIHAM MAHGOUB M.D.

Infectious Disease

1,706

$789K

65
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 62%

$463
Average prescription price

Avg: $471

DEBORAH GOLDSTEIN MD

Infectious Disease

2,183

$980K

75
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 62%

$449
Average prescription price

Avg: $471

ROBERT DELAPENHA M.D.

Infectious Disease

2,001

$833K

98
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 62%

$416
Average prescription price

Avg: $471

STEPHEN ABBOTT MD

Infectious Disease

835

$347K

65
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 62%

$416
Average prescription price

Avg: $471

AMY SITAPATI MD

Infectious Disease

7,621

$2.86M

156
21 are 65+

30%
patients receiving schedule two controlled substances

Avg: 2%

34%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 62%

$375
Average prescription price

Avg: $471

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank